25.02.21|Sophie ShulmanTal Zaks: I never imagined that I’d develop a vaccine for the worst pandemic of our times
25.02.21|Mickey Greenfeld“Through his leadership over the past year in Moderna’s response to the Covid-19 pandemic, Tal has made a contribution that extends beyond Moderna to all of society,” says CEO
25.02.21|Sophie ShulmanTal Zaks says the drugmaker has already produced a booster shot to counter the South African variant, says his mom in Israel received the competition’s vaccine
10.01.21|Elihay VidalIsrael is well on its way to vaccinating its entire adult population and in exchange for delivering millions of vaccine doses, the government has pledged to give drugmaker Pfizer medical data on the millions of vaccine recipients from the health system’s vast databases
06.01.21|ReutersTwo weeks into its vaccination drive, Israel has reached nearly 15% of the population by paying premium prices, relying on universal healthcare, and minimizing waste
05.01.21|ReutersThe U.S. drugmaker says Israel is the first county outside of North America to authorize the use of its Covid-19 shots
13.12.20|Sophie ShulmanAn urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
30.11.20|CTechDirector of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021
24.11.20|Yafit Ovadia“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
17.11.20|CTechVaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference
16.11.20|CTechCTech Daily Roundup: In the absence of acquisitions, IPOs are swooping in to save the tech scene
16.11.20|Sophie ShulmanIsraeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
16.11.20|ReutersA key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute
10.08.20|Sophie ShulmanGovernments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
02.08.20|Sophie ShulmanModerna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
16.06.20|CTechCTech Daily Roundup: Coronavirus-led protectionism poses a challenge to both our economies, says Irish ambassador to Israel
16.06.20|Ynetnews and CTechModerna announced it was concluding its phase two testing for the vaccine and plans to begin phase three with 30,000 participants in July. The company claimed it could start production of the vaccine as soon as September of this year